Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Change in Accured Expenses (2020 - 2025)

GoHealth's Change in Accured Expenses history spans 6 years, with the latest figure at $23000.0 for Q3 2025.

  • For Q3 2025, Change in Accured Expenses rose 101.26% year-over-year to $23000.0; the TTM value through Sep 2025 reached $31.9 million, up 170.47%, while the annual FY2024 figure was -$8.6 million, 393.96% down from the prior year.
  • Change in Accured Expenses for Q3 2025 was $23000.0 at GoHealth, down from $35.3 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $35.7 million in Q4 2024 and bottomed at -$39.1 million in Q1 2025.
  • The 5-year median for Change in Accured Expenses is -$783000.0 (2021), against an average of $1.3 million.
  • The largest annual shift saw Change in Accured Expenses plummeted 2249.04% in 2022 before it surged 3436.2% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $20.1 million in 2021, then skyrocketed by 41.14% to $28.3 million in 2022, then tumbled by 103.78% to -$1.1 million in 2023, then soared by 3436.2% to $35.7 million in 2024, then plummeted by 99.94% to $23000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Change in Accured Expenses are $23000.0 (Q3 2025), $35.3 million (Q2 2025), and -$39.1 million (Q1 2025).